Merck Showcases New Innovations at INTERPHEX 2018
Saturday, March 31, 2018
Merck, a leading science and technology company, will introduce three new products for the flexible manufacturing of biologics at INTERPHEX, April 17-19, in New York City, USA.
On display at Booth #2841 will be:
- • Pellicon® Capsule with Ultracel® Membrane. This first-of-its-kind single-use tangential flow filtration device is used for bioprocessing of antibody-drug conjugates and monoclonal antibodies.
- • Millipak® Final Fill Filter. These filters provide maximum product yield in high-value, small-volume processing.
- • Mobius® Power MIX 2,500-Liter and 3,000-Liter large-scale single-use mixers. These mixing systems combine high-performance technology with design elements that make them easy to use when mixing the most challenging buffers, media and biopharmaceutical ingredients.
Attendees are invited to learn more about how Merck is innovating flexible manufacturing to save customers both time and money.
Merck experts will share best practices and insights across a variety of pharmaceutical manufacturing topics at the following presentations and panel discussions:
• Formulation and Delivery of Biologics and Complex Small Molecule Compounds – Panel Discussion
- • April 17, 10:15 a.m., INTERPHEX LIVE!
- • Panelist: Jeff Shumway, associate director, Formulation & Drug Delivery
• A Molecule’s Journey – Breaking Down Roadblocks to Commercial Success – Navigating Through the Important Considerations Necessary to Successfully Bring a Biologic Molecule to Market
- • April 17, 10:30 a.m. – 11:15 a.m.
- • Christian Cattaruzza, director, Global Services Marketing & Development, BioPharm Process Solutions
• Flexibility Without Compromise – A Novel Approach to Single-use System Design to Increase Speed, Reduce Cost and Enhance Supply Reliability
- • April 17, 11:30 a.m. – 12:00 p.m.
- • Sara Bell, senior marketing manager, Single-use Solutions
• Continuous Manufacturing for Biopharm, Visions of an End-to-End Approach – Panel Discussion
- • April 17, 2:15 p.m. – 3:00 p.m.
- • Panelist: Merrilee Whitney, head of Next-Generation Bioprocessing
• Single-use Product Recycling: Collaboration & Innovation to Address a Challenging Waste Stream
- • April 17, 3:00 p.m. – 3:30 p.m.
- • Jacqueline Ignacio, global manager, Customer Sustainability Solutions
• Case Study: Capacity Expansion and Conversion to Single-Use Bioprocessing at an Existing cGMP CDMO Facility
- • April 17, 3:30 p.m. – 4:15 p.m.
- • Jerome Pionchon, engineering consultant, BioReliance® End-to-End Solutions
Your Contact
Karen Tiano
+49 6151 72 44461
About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of €15.3 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
